Swine vesicular disease
Swine vesicular disease (SVD) is a highly contagious viral disease that affects swine. It is caused by the Swine vesicular disease virus (SVDV), a member of the Picornaviridae family. The disease is characterized by the formation of vesicles, or blisters, on the feet and snout of infected pigs.
Etiology
The causative agent of Swine vesicular disease is the Swine vesicular disease virus, a single-stranded RNA virus of the genus Enterovirus within the family Picornaviridae. The virus is resistant to a wide range of pH levels and can survive in dried pork products for several months.
Clinical Signs and Diagnosis
Clinical signs of SVD include fever, lameness, and the formation of vesicles on the coronary bands, snout, and inside the mouth. The disease is often confused with Foot-and-mouth disease due to the similarity in clinical signs. Diagnosis is typically confirmed through laboratory testing, including virus isolation, serology, and polymerase chain reaction (PCR) tests.
Transmission and Epidemiology
SVD is primarily spread through direct contact with infected pigs or contaminated fomites. The virus can also be spread through the consumption of contaminated pork products. SVD has been reported in several countries in Europe and Asia, and is a notifiable disease under the World Organisation for Animal Health (OIE).
Prevention and Control
Prevention and control measures for SVD include strict biosecurity practices, movement restrictions, and the culling of infected herds. There is currently no effective vaccine for SVD.
Economic Impact
The economic impact of SVD is significant, primarily due to trade restrictions imposed on affected countries. The disease can also cause reduced growth rates and weight loss in infected pigs, leading to decreased productivity.
See Also
This animal disease related article is a stub. You can help WikiMD by expanding it.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian